Published in PLoS One on October 11, 2012
Applications of in vivo imaging in the evaluation of the pathophysiology of viral and bacterial infections and in development of countermeasures to BSL3/4 pathogens. Mol Imaging Biol (2015) 0.83
Essential role for the response regulator PmrA in Coxiella burnetii type 4B secretion and colonization of mammalian host cells. J Bacteriol (2014) 0.83
Yersinia pestis Requires Host Rab1b for Survival in Macrophages. PLoS Pathog (2015) 0.76
The in vitro and in vivo effects of constitutive light expression on a bioluminescent strain of the mouse enteropathogen Citrobacter rodentium. PeerJ (2016) 0.76
Novel Synthesis of Kanamycin Conjugated Gold Nanoparticles with Potent Antibacterial Activity. Front Microbiol (2016) 0.75
LuxCDE-luxAB-based promoter reporter system to monitor the Yersinia enterocolitica O:3 gene expression in vivo. PLoS One (2017) 0.75
The impact of "omic" and imaging technologies on assessing the host immune response to biodefence agents. J Immunol Res (2014) 0.75
A Bioluminescent Francisella tularensis SCHU S4 Strain Enables Noninvasive Tracking of Bacterial Dissemination and the Evaluation of Antibiotics in an Inhalational Mouse Model of Tularemia. Antimicrob Agents Chemother (2016) 0.75
Yersinia pestis--etiologic agent of plague. Clin Microbiol Rev (1997) 14.63
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45
Molecular biology of bacterial bioluminescence. Microbiol Rev (1991) 5.94
A Tn7-based broad-range bacterial cloning and expression system. Nat Methods (2005) 4.66
A surface protease and the invasive character of plague. Science (1992) 4.44
Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity. Proc Natl Acad Sci U S A (2005) 3.01
A plasminogen-activating protease specifically controls the development of primary pneumonic plague. Science (2007) 2.69
Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem Biol (2003) 2.61
Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci U S A (2007) 2.56
Anatomy and nomenclature of murine lymph nodes: Descriptive study and nomenclatory standardization in BALB/cAnNCrl mice. J Immunol Methods (2006) 2.54
Cat-transmitted fatal pneumonic plague in a person who traveled from Colorado to Arizona. Am J Trop Med Hyg (1994) 2.42
Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague. Proc Natl Acad Sci U S A (2006) 2.31
The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis. Infect Immun (2003) 1.95
RovA, a global regulator of Yersinia pestis, specifically required for bubonic plague. Proc Natl Acad Sci U S A (2006) 1.92
Studies on the role of plasminogen activator in systemic infection by virulent Yersinia pestis strain C092. Microb Pathog (1997) 1.88
Lymph node mapping in the mouse. J Immunol Methods (2007) 1.84
Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. Infect Immun (1999) 1.66
Visualization of murine intranasal dosing efficiency using luminescent Francisella tularensis: effect of instillation volume and form of anesthesia. PLoS One (2012) 1.20
In vivo Bioluminescence Imaging of Burkholderia mallei Respiratory Infection and Treatment in the Mouse Model. Front Microbiol (2011) 1.14
Monitoring of gene expression in bacteria during infections using an adaptable set of bioluminescent, fluorescent and colorigenic fusion vectors. PLoS One (2011) 1.14
Bioluminescent diagnostic imaging to characterize altered respiratory tract colonization by the burkholderia pseudomallei capsule mutant. Front Microbiol (2011) 1.04
Targeting type III secretion in Yersinia pestis. Antimicrob Agents Chemother (2008) 1.00
Imaging of bubonic plague dynamics by in vivo tracking of bioluminescent Yersinia pestis. PLoS One (2012) 0.98
The RACK1 signaling scaffold protein selectively interacts with Yersinia pseudotuberculosis virulence function. PLoS One (2011) 0.98
A novel autotransporter adhesin is required for efficient colonization during bubonic plague. Infect Immun (2008) 0.97
Construction of a bioluminescence reporter plasmid for Francisella tularensis. Plasmid (2010) 0.95
Analysis of Yersinia enterocolitica invasin expression in vitro and in vivo using a novel luxCDABE reporter system. Microbiology (2010) 0.90
In vivo analysis of Yersinia enterocolitica infection using luxCDABE. FEMS Microbiol Lett (2010) 0.89
The evolution of the bacterial luciferase gene cassette (lux) as a real-time bioreporter. Sensors (Basel) (2012) 0.85
Novel genetic tools for diaminopimelic acid selection in virulence studies of Yersinia pestis. PLoS One (2011) 0.81
Model systems to study plague pathogenesis and develop new therapeutics. Front Microbiol (2010) 0.79
Identification and characterisation of a novel adhesin Ifp in Yersinia pseudotuberculosis. BMC Microbiol (2011) 0.79
A plasmid-encoded nicotinamidase (PncA) is essential for infectivity of Borrelia burgdorferi in a mammalian host. Mol Microbiol (2003) 3.17
Crystal structure of Lyme disease variable surface antigen VlsE of Borrelia burgdorferi. J Biol Chem (2002) 1.62
The Yersinia pestis autotransporter YapC mediates host cell binding, autoaggregation and biofilm formation. Microbiology (2008) 1.03
Invasin and beyond: regulation of Yersinia virulence by RovA. Trends Microbiol (2004) 0.99
The dependence of the Yersinia pestis capsule on pathogenesis is influenced by the mouse background. Infect Immun (2010) 0.95
Expression during host infection and localization of Yersinia pestis autotransporter proteins. J Bacteriol (2011) 0.93
Bioluminescent imaging of bacteria during mouse infection. Methods Mol Biol (2014) 0.77